Loading…
Matrix-degrading proteinases are shed in membrane vesicles by ovarian cancer cells in vivo and in vitro
The in vitro release of matrix-degrading proteinases from breast cancer cells is associated in part with shed membrane vesicles. To determine whether shed vesicles might play a similar role in ovarian cancer cells, we analyzed the shedding phenomenon in vivo and in vitro as well as the enzymatic con...
Saved in:
Published in: | Clinical & experimental metastasis 1999-03, Vol.17 (2), p.131 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | |
container_issue | 2 |
container_start_page | 131 |
container_title | Clinical & experimental metastasis |
container_volume | 17 |
creator | Dolo, V D'Ascenzo, S Violini, S Pompucci, L Festuccia, C Ginestra, A Vittorelli, M L Canevari, S Pavan, A |
description | The in vitro release of matrix-degrading proteinases from breast cancer cells is associated in part with shed membrane vesicles. To determine whether shed vesicles might play a similar role in ovarian cancer cells, we analyzed the shedding phenomenon in vivo and in vitro as well as the enzymatic content of their vesicles. This is the first time that an immunoelectron microscopical analysis revealed membrane vesicles carrying tumor-associated antigen alpha-Folate Receptor (alpha-FR), circulating in biological fluids (ascites and serum) of an ovarian carcinoma patient. These vesicles were trapped in a fiber network with characteristic fibrin periodicity. An ovarian cancer cell line (CABA I) established from ascitic fluid cells of this patient, grew in Matrigel and formed tubular structures suggesting invasive capability. Immunofluorescence analysis demonstrated strong cytoplasmic staining of CABA I cells with anti-matrix metalloproteinase-9 (MMP-9) and anti-urokinase-type plasminogen activator (uPA) antibodies. CABA I cells shed membrane vesicles, which were morphologically similar to those identified in vivo, as determined by electron microscopy. Gelatin zymography of vesicles isolated both in vivo and in vitro revealed major gelatinolytic bands of the MMP family, identified as the zymogen and active forms of gelatinase B (MMP-9) and gelatinase A (MMP-2). By casein-plasminogen zymography we observed high-molecular weight (HMW)-uPA and plasmin bands. Incubation of purified vesicles from CABA I cells with Matrigel led to cleavage of Matrigel components. Taken together, our results point to a possible role of shed vesicles, both in vivo and in vitro, in proteolysis that mediates invasion and spread of ovarian epithelial carcinoma cells. |
doi_str_mv | 10.1023/A:1006500406240 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_journals_214159596</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>387002061</sourcerecordid><originalsourceid>FETCH-LOGICAL-p135t-740a9c166e5624de7b8773041c0b77c5a03085c743a7bc3bfae34d4782966e103</originalsourceid><addsrcrecordid>eNo1kM1PwzAMxSMEYmNw5oYi7gXnq2m5TRNf0hAXOFdp6o1MbTqSrmL_PUEbJz_JPz_7mZBrBncMuLifPzCAXAFIyLmEEzJlSotMc52fkinwnGdQlMWEXMS4gYRpXZyTCQPJGAM1Jes3MwT3kzW4DqZxfk23oR_QeRMxUhOQxi9sqPO0w64OxiMdMTrbpm69p_1ogjOeWuMtBmqxbeMfPLqxp8Y3Bz2E_pKcrUwb8epYZ-Tz6fFj8ZIt359fF_NltmVCDZmWYErL8hxVytOgrgutRbrWQq21VQYEFMpqKYyurahXBoVspC54mWYYiBm5PfimGN87jEO16XfBp5UVZ5KpUpV5gm6O0K7usKm2wXUm7Kv_t4hfADVjug</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>214159596</pqid></control><display><type>article</type><title>Matrix-degrading proteinases are shed in membrane vesicles by ovarian cancer cells in vivo and in vitro</title><source>Springer Nature</source><creator>Dolo, V ; D'Ascenzo, S ; Violini, S ; Pompucci, L ; Festuccia, C ; Ginestra, A ; Vittorelli, M L ; Canevari, S ; Pavan, A</creator><creatorcontrib>Dolo, V ; D'Ascenzo, S ; Violini, S ; Pompucci, L ; Festuccia, C ; Ginestra, A ; Vittorelli, M L ; Canevari, S ; Pavan, A</creatorcontrib><description>The in vitro release of matrix-degrading proteinases from breast cancer cells is associated in part with shed membrane vesicles. To determine whether shed vesicles might play a similar role in ovarian cancer cells, we analyzed the shedding phenomenon in vivo and in vitro as well as the enzymatic content of their vesicles. This is the first time that an immunoelectron microscopical analysis revealed membrane vesicles carrying tumor-associated antigen alpha-Folate Receptor (alpha-FR), circulating in biological fluids (ascites and serum) of an ovarian carcinoma patient. These vesicles were trapped in a fiber network with characteristic fibrin periodicity. An ovarian cancer cell line (CABA I) established from ascitic fluid cells of this patient, grew in Matrigel and formed tubular structures suggesting invasive capability. Immunofluorescence analysis demonstrated strong cytoplasmic staining of CABA I cells with anti-matrix metalloproteinase-9 (MMP-9) and anti-urokinase-type plasminogen activator (uPA) antibodies. CABA I cells shed membrane vesicles, which were morphologically similar to those identified in vivo, as determined by electron microscopy. Gelatin zymography of vesicles isolated both in vivo and in vitro revealed major gelatinolytic bands of the MMP family, identified as the zymogen and active forms of gelatinase B (MMP-9) and gelatinase A (MMP-2). By casein-plasminogen zymography we observed high-molecular weight (HMW)-uPA and plasmin bands. Incubation of purified vesicles from CABA I cells with Matrigel led to cleavage of Matrigel components. Taken together, our results point to a possible role of shed vesicles, both in vivo and in vitro, in proteolysis that mediates invasion and spread of ovarian epithelial carcinoma cells.</description><identifier>ISSN: 0262-0898</identifier><identifier>EISSN: 1573-7276</identifier><identifier>DOI: 10.1023/A:1006500406240</identifier><identifier>PMID: 10411105</identifier><identifier>CODEN: CEXMD2</identifier><language>eng</language><publisher>Netherlands: Springer Nature B.V</publisher><subject>Adenocarcinoma, Papillary - enzymology ; Biomarkers, Tumor - analysis ; Blotting, Western ; Cell Membrane - enzymology ; Cell Membrane - ultrastructure ; Female ; Fluorescent Antibody Technique ; Humans ; In Vitro Techniques ; Metalloendopeptidases - physiology ; Metalloendopeptidases - secretion ; Microscopy, Electron ; Middle Aged ; Ovarian Neoplasms - enzymology ; Plasminogen Activators - metabolism ; Tumor Cells, Cultured</subject><ispartof>Clinical & experimental metastasis, 1999-03, Vol.17 (2), p.131</ispartof><rights>Copyright Kluwer Academic Publishers Mar 1999</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10411105$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dolo, V</creatorcontrib><creatorcontrib>D'Ascenzo, S</creatorcontrib><creatorcontrib>Violini, S</creatorcontrib><creatorcontrib>Pompucci, L</creatorcontrib><creatorcontrib>Festuccia, C</creatorcontrib><creatorcontrib>Ginestra, A</creatorcontrib><creatorcontrib>Vittorelli, M L</creatorcontrib><creatorcontrib>Canevari, S</creatorcontrib><creatorcontrib>Pavan, A</creatorcontrib><title>Matrix-degrading proteinases are shed in membrane vesicles by ovarian cancer cells in vivo and in vitro</title><title>Clinical & experimental metastasis</title><addtitle>Clin Exp Metastasis</addtitle><description>The in vitro release of matrix-degrading proteinases from breast cancer cells is associated in part with shed membrane vesicles. To determine whether shed vesicles might play a similar role in ovarian cancer cells, we analyzed the shedding phenomenon in vivo and in vitro as well as the enzymatic content of their vesicles. This is the first time that an immunoelectron microscopical analysis revealed membrane vesicles carrying tumor-associated antigen alpha-Folate Receptor (alpha-FR), circulating in biological fluids (ascites and serum) of an ovarian carcinoma patient. These vesicles were trapped in a fiber network with characteristic fibrin periodicity. An ovarian cancer cell line (CABA I) established from ascitic fluid cells of this patient, grew in Matrigel and formed tubular structures suggesting invasive capability. Immunofluorescence analysis demonstrated strong cytoplasmic staining of CABA I cells with anti-matrix metalloproteinase-9 (MMP-9) and anti-urokinase-type plasminogen activator (uPA) antibodies. CABA I cells shed membrane vesicles, which were morphologically similar to those identified in vivo, as determined by electron microscopy. Gelatin zymography of vesicles isolated both in vivo and in vitro revealed major gelatinolytic bands of the MMP family, identified as the zymogen and active forms of gelatinase B (MMP-9) and gelatinase A (MMP-2). By casein-plasminogen zymography we observed high-molecular weight (HMW)-uPA and plasmin bands. Incubation of purified vesicles from CABA I cells with Matrigel led to cleavage of Matrigel components. Taken together, our results point to a possible role of shed vesicles, both in vivo and in vitro, in proteolysis that mediates invasion and spread of ovarian epithelial carcinoma cells.</description><subject>Adenocarcinoma, Papillary - enzymology</subject><subject>Biomarkers, Tumor - analysis</subject><subject>Blotting, Western</subject><subject>Cell Membrane - enzymology</subject><subject>Cell Membrane - ultrastructure</subject><subject>Female</subject><subject>Fluorescent Antibody Technique</subject><subject>Humans</subject><subject>In Vitro Techniques</subject><subject>Metalloendopeptidases - physiology</subject><subject>Metalloendopeptidases - secretion</subject><subject>Microscopy, Electron</subject><subject>Middle Aged</subject><subject>Ovarian Neoplasms - enzymology</subject><subject>Plasminogen Activators - metabolism</subject><subject>Tumor Cells, Cultured</subject><issn>0262-0898</issn><issn>1573-7276</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><recordid>eNo1kM1PwzAMxSMEYmNw5oYi7gXnq2m5TRNf0hAXOFdp6o1MbTqSrmL_PUEbJz_JPz_7mZBrBncMuLifPzCAXAFIyLmEEzJlSotMc52fkinwnGdQlMWEXMS4gYRpXZyTCQPJGAM1Jes3MwT3kzW4DqZxfk23oR_QeRMxUhOQxi9sqPO0w64OxiMdMTrbpm69p_1ogjOeWuMtBmqxbeMfPLqxp8Y3Bz2E_pKcrUwb8epYZ-Tz6fFj8ZIt359fF_NltmVCDZmWYErL8hxVytOgrgutRbrWQq21VQYEFMpqKYyurahXBoVspC54mWYYiBm5PfimGN87jEO16XfBp5UVZ5KpUpV5gm6O0K7usKm2wXUm7Kv_t4hfADVjug</recordid><startdate>199903</startdate><enddate>199903</enddate><creator>Dolo, V</creator><creator>D'Ascenzo, S</creator><creator>Violini, S</creator><creator>Pompucci, L</creator><creator>Festuccia, C</creator><creator>Ginestra, A</creator><creator>Vittorelli, M L</creator><creator>Canevari, S</creator><creator>Pavan, A</creator><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>3V.</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8FE</scope><scope>8FG</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>P5Z</scope><scope>P62</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope></search><sort><creationdate>199903</creationdate><title>Matrix-degrading proteinases are shed in membrane vesicles by ovarian cancer cells in vivo and in vitro</title><author>Dolo, V ; D'Ascenzo, S ; Violini, S ; Pompucci, L ; Festuccia, C ; Ginestra, A ; Vittorelli, M L ; Canevari, S ; Pavan, A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p135t-740a9c166e5624de7b8773041c0b77c5a03085c743a7bc3bfae34d4782966e103</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Adenocarcinoma, Papillary - enzymology</topic><topic>Biomarkers, Tumor - analysis</topic><topic>Blotting, Western</topic><topic>Cell Membrane - enzymology</topic><topic>Cell Membrane - ultrastructure</topic><topic>Female</topic><topic>Fluorescent Antibody Technique</topic><topic>Humans</topic><topic>In Vitro Techniques</topic><topic>Metalloendopeptidases - physiology</topic><topic>Metalloendopeptidases - secretion</topic><topic>Microscopy, Electron</topic><topic>Middle Aged</topic><topic>Ovarian Neoplasms - enzymology</topic><topic>Plasminogen Activators - metabolism</topic><topic>Tumor Cells, Cultured</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dolo, V</creatorcontrib><creatorcontrib>D'Ascenzo, S</creatorcontrib><creatorcontrib>Violini, S</creatorcontrib><creatorcontrib>Pompucci, L</creatorcontrib><creatorcontrib>Festuccia, C</creatorcontrib><creatorcontrib>Ginestra, A</creatorcontrib><creatorcontrib>Vittorelli, M L</creatorcontrib><creatorcontrib>Canevari, S</creatorcontrib><creatorcontrib>Pavan, A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>ProQuest Central (Corporate)</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health & Medicine (ProQuest)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest Science Journals</collection><collection>ProQuest advanced technologies & aerospace journals</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><jtitle>Clinical & experimental metastasis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dolo, V</au><au>D'Ascenzo, S</au><au>Violini, S</au><au>Pompucci, L</au><au>Festuccia, C</au><au>Ginestra, A</au><au>Vittorelli, M L</au><au>Canevari, S</au><au>Pavan, A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Matrix-degrading proteinases are shed in membrane vesicles by ovarian cancer cells in vivo and in vitro</atitle><jtitle>Clinical & experimental metastasis</jtitle><addtitle>Clin Exp Metastasis</addtitle><date>1999-03</date><risdate>1999</risdate><volume>17</volume><issue>2</issue><spage>131</spage><pages>131-</pages><issn>0262-0898</issn><eissn>1573-7276</eissn><coden>CEXMD2</coden><abstract>The in vitro release of matrix-degrading proteinases from breast cancer cells is associated in part with shed membrane vesicles. To determine whether shed vesicles might play a similar role in ovarian cancer cells, we analyzed the shedding phenomenon in vivo and in vitro as well as the enzymatic content of their vesicles. This is the first time that an immunoelectron microscopical analysis revealed membrane vesicles carrying tumor-associated antigen alpha-Folate Receptor (alpha-FR), circulating in biological fluids (ascites and serum) of an ovarian carcinoma patient. These vesicles were trapped in a fiber network with characteristic fibrin periodicity. An ovarian cancer cell line (CABA I) established from ascitic fluid cells of this patient, grew in Matrigel and formed tubular structures suggesting invasive capability. Immunofluorescence analysis demonstrated strong cytoplasmic staining of CABA I cells with anti-matrix metalloproteinase-9 (MMP-9) and anti-urokinase-type plasminogen activator (uPA) antibodies. CABA I cells shed membrane vesicles, which were morphologically similar to those identified in vivo, as determined by electron microscopy. Gelatin zymography of vesicles isolated both in vivo and in vitro revealed major gelatinolytic bands of the MMP family, identified as the zymogen and active forms of gelatinase B (MMP-9) and gelatinase A (MMP-2). By casein-plasminogen zymography we observed high-molecular weight (HMW)-uPA and plasmin bands. Incubation of purified vesicles from CABA I cells with Matrigel led to cleavage of Matrigel components. Taken together, our results point to a possible role of shed vesicles, both in vivo and in vitro, in proteolysis that mediates invasion and spread of ovarian epithelial carcinoma cells.</abstract><cop>Netherlands</cop><pub>Springer Nature B.V</pub><pmid>10411105</pmid><doi>10.1023/A:1006500406240</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0262-0898 |
ispartof | Clinical & experimental metastasis, 1999-03, Vol.17 (2), p.131 |
issn | 0262-0898 1573-7276 |
language | eng |
recordid | cdi_proquest_journals_214159596 |
source | Springer Nature |
subjects | Adenocarcinoma, Papillary - enzymology Biomarkers, Tumor - analysis Blotting, Western Cell Membrane - enzymology Cell Membrane - ultrastructure Female Fluorescent Antibody Technique Humans In Vitro Techniques Metalloendopeptidases - physiology Metalloendopeptidases - secretion Microscopy, Electron Middle Aged Ovarian Neoplasms - enzymology Plasminogen Activators - metabolism Tumor Cells, Cultured |
title | Matrix-degrading proteinases are shed in membrane vesicles by ovarian cancer cells in vivo and in vitro |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T12%3A14%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Matrix-degrading%20proteinases%20are%20shed%20in%20membrane%20vesicles%20by%20ovarian%20cancer%20cells%20in%20vivo%20and%20in%20vitro&rft.jtitle=Clinical%20&%20experimental%20metastasis&rft.au=Dolo,%20V&rft.date=1999-03&rft.volume=17&rft.issue=2&rft.spage=131&rft.pages=131-&rft.issn=0262-0898&rft.eissn=1573-7276&rft.coden=CEXMD2&rft_id=info:doi/10.1023/A:1006500406240&rft_dat=%3Cproquest_pubme%3E387002061%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p135t-740a9c166e5624de7b8773041c0b77c5a03085c743a7bc3bfae34d4782966e103%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=214159596&rft_id=info:pmid/10411105&rfr_iscdi=true |